Zura Bio Limited (ZURA)

Profile

Full Name

Zura Bio Limited

Ticker Symbol

ZURA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 21, 2023

Indexes

Not included

Website

http://zurabio.com

Employees

30

Key Details

Price

$1.23(+6.96%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.60(+71.29% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.23
ZURA price is $1.23

30-Day Relative Volume

0.77
ZURA 30-day relative volume is 0.77

Price Performance

Price Most recent change

+6.96%
ZURA price was up +6.96% on Apr 17, 2025

Price YTD change

-50.8%
ZURA price is down -50.8% since January 1st

Price 1-year change

-60.7%
ZURA price is down -60.7% year-on-year

Price 3-year change

-
ZURA price 3-year change is unknown

Price Range

Price All-time high

$37.55
ZURA price is currently -96.72% below its historical high of $37.55

Price 3-year low

$0.97
ZURA price is currently +26.80% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$84.10M
ZURA market capitalization is $84.10 million

Market cap 3-year change

-
ZURA market capitalization 3-year change is unknown

Market cap All-time high

$898.40M
ZURA market capitalization is currently -90.64% below its historical high of $898.40 million

Market cap sector rank

46.26%
ZURA market capitalization is higher than 46.26% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+56.85%
ZURA shares outstanding is up +56.85% year-on-year

Shares Outstanding 3-Year Change

-
ZURA shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.53
ZURA beta is 1.53

200-day SMA

$2.87
ZURA price is currently -57.07% below its 200-day simple moving average

50-day SMA

$1.30
ZURA price is currently -5.46% below its 50-day simple moving average

RSI

49.63
ZURA 14-day relative strength index is 49.63

Volume

0.77
ZURA 30-day relative volume is 0.77

ATR

$0.15
ZURA average true range is $0.15

10-day Historical Volatility

111.68%
ZURA 10-day historical volatility is 111.68%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ZURA annual revenue value is unknown

Revenue Analysts estimate

-
ZURA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ZURA annual revenue 1-year change is unknown

Revenue Sector rank

-
ZURA annual revenue is unknown

EPS

EPS

-$0.60
ZURA annual earnings per share is -$0.60

EPS Analysts estimate

-$0.76
ZURA annual earnings per share is currently -21.05% lower than the consensus analysts' forecast

EPS 1-year change

+71.29%
ZURA annual earnings per share is up +71.29% year-on-year

EPS Sector rank

65.29%
ZURA annual earnings per share is higher than 65.29% of companies in Healthcare sector

Profit

Gross profit

-
ZURA annual gross profit value is unknown

Gross margin

-
ZURA annual gross profit margin value is unknown

Operating profit

-$55.19M
ZURA annual operating income is -$55.19 million

Operating margin

-
ZURA annual operating profit margin value is unknown

Net income

-$52.40M
ZURA annual net profit is -$52.40 million

Net margin

-
ZURA annual net profit margin value is unknown

Expenses

Total expenses

$55.19M
ZURA annual total expenses is $55.19 million

Operating expenses

$55.19M
ZURA annual total operating expenses is $55.19 million

Cost of goods sold

-
ZURA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$30.79M
ZURA annual SGA is $30.79 million

Depreciation and amortization

$9000.00
ZURA annual depreciation & amortization is $9000.00

Interest expense

-
ZURA annual interest expense value is unknown

Income tax

$0.00
ZURA annual income tax is $0.00

EBIT & EBITDA

EBIT

-$55.19M
ZURA annual earnings before interest & taxes is -$55.19 million

EBITDA

-$55.18M
ZURA annual EBITDA is -$55.18 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$179.53M
ZURA annual total assets is $179.53 million

Non current assets

$789.00K
ZURA annual long term assets is $789.00 thousand

Current assets

$178.74M
ZURA annual total current assets is $178.74 million

Cash and cash equivalents

$176.50M
ZURA annual cash & cash equivalents is $176.50 million

Accounts receivable

-
ZURA annual accounts receivable value is unknown

Inventory

-
ZURA annual inventory value is unknown

Liabilities

Total liabilities

$19.51M
ZURA annual total liabilities is $19.51 million

Long term liabilities

$0.00
ZURA annual total long term liabilities is $0.00

Current liabilities

$19.51M
ZURA annual total current liabilities is $19.51 million

Accounts payable

$733.00K
ZURA annual accounts payable is $733.00 thousand

Debt

Total debt

$0.00
ZURA annual total debt is $0.00

Total debt 1-year change

0%
ZURA {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
ZURA annual long term debt value is unknown

Short term debt

-
ZURA annual short term debt value is unknown

Equity & Capital

Shareholders equity

$146.81M
ZURA annual stockholders equity is $146.81 million

Book value

$146.81M
ZURA annual book value is $146.81 million

Retained earnings

-$155.90M
ZURA annual retained earnings is -$155.90 million

Working capital

$159.23M
ZURA annual working capital is $159.23 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$28.08M
ZURA annual cash flow from operations is -$28.08 million

Cash from operations 1-year change

-86.5%
ZURA annual cash flow from operations is down -86.5% year-on-year

Cash from investing

-$5.08M
ZURA annual cash flow from investing activities is -$5.08 million

Cash from investing 1-year change

+36.56%
ZURA annual cash flow from investing activities is up +36.56% year-on-year

Cash from financing

$109.84M
ZURA annual cash flow from financing activities is $109.84 million

Cash from financing 1-year change

-9.44%
ZURA annual cash flow from financing activities is down -9.44% year-on-year

CAPEX

CAPEX

-
ZURA annual capital expenditures value is unknown

CAPEX 1-year change

-
ZURA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$33.15M
ZURA annual free cash flow is -$33.15 million

Free cash flow 1-year change

-43.8%
ZURA annual free cash flow is down -43.8% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ZURA annual gross profit margin value is unknown

Operating margin

-
ZURA annual operating profit margin value is unknown

Net margin

-
ZURA annual net profit margin value is unknown

ROA & ROE

ROA

-29.19%
ZURA annual return on assets is -29.19%

ROE

-35.69%
ZURA annual return on equity is -35.69%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ZURA price to earnings ratio value is unknown

PE ratio Sector rank

-
ZURA price to earnings ratio is unknown

PB Ratio

PB ratio

0.57
ZURA price to book ratio is 0.57

PB ratio Sector rank

31.74%
ZURA price to book ratio is higher than 31.74% of companies in Healthcare sector

PS Ratio

PS ratio

-
ZURA price to sales ratio value is unknown

PS ratio Sector rank

-
ZURA price to sales ratio is unknown

Enterprise value

Enterprise value

-$92.40M
ZURA enterprise value is -$92.40 million

Enterprise value Sector rank

0.58%
ZURA enterprise value is higher than 0.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

1.67
ZURA EV/EBITDA is 1.67

EV/EBITDA Sector rank

75.72%
ZURA EV/EBITDA is higher than 75.72% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.16
ZURA annual current ratio is 9.16

Quick ratio

-
ZURA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ZURA annual debt to equity ratio is 0.00

Interest coverage ratio

-
ZURA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ZURA piotroski f-score value is unknown

Altman Z-Score

-
ZURA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 3, 25 HC Wainwright & Co.
Neutral
Mar 26, 25 Oppenheimer
Outperform
Mar 26, 25 Guggenheim
Buy
Mar 26, 25 Chardan Capital
Buy
Dec 24, 24 HC Wainwright & Co.
Neutral
Dec 11, 24 Cantor Fitzgerald
Overweight
Nov 18, 24 HC Wainwright & Co.
Neutral
Nov 11, 24 HC Wainwright & Co.
Neutral
Nov 9, 24 Chardan Capital
Buy
Nov 4, 24 Leerink Partners
Outperform

Institutional Ownership

Similar stocks

HLVX logo
HilleVax (HLVX)
CRDL logo
Cardiol Therapeutics (CRDL)
Climb Bio (CLYM)
CRVO logo
CervoMed (CRVO)
SRZN logo
Surrozen (SRZN)
SY logo
So-Young International (SY)
QIPT logo
Quipt Home Medical (QIPT)
Basel Medical Group Ltd (BMGL)
MBOT logo
Microbot Medical (MBOT)
  • What is the ticker symbol for Zura Bio Limited?
  • Does Zura Bio Limited pay dividends?
  • What sector is Zura Bio Limited in?
  • What industry is Zura Bio Limited in?
  • What country is Zura Bio Limited based in?
  • When did Zura Bio Limited go public?
  • Is Zura Bio Limited in the S&P 500?
  • Is Zura Bio Limited in the NASDAQ 100?
  • Is Zura Bio Limited in the Dow Jones?
  • When was Zura Bio Limited's last earnings report?
  • When does Zura Bio Limited report earnings?
  • Should I buy Zura Bio Limited stock now?

What is the ticker symbol for Zura Bio Limited?

The ticker symbol for Zura Bio Limited is NASDAQ:ZURA

Does Zura Bio Limited pay dividends?

No, Zura Bio Limited does not pay dividends

What sector is Zura Bio Limited in?

Zura Bio Limited is in the Healthcare sector

What industry is Zura Bio Limited in?

Zura Bio Limited is in the Biotechnology industry

What country is Zura Bio Limited based in?

Zura Bio Limited is headquartered in United States

When did Zura Bio Limited go public?

Zura Bio Limited's initial public offering (IPO) was on March 21, 2023

Is Zura Bio Limited in the S&P 500?

No, Zura Bio Limited is not included in the S&P 500 index

Is Zura Bio Limited in the NASDAQ 100?

No, Zura Bio Limited is not included in the NASDAQ 100 index

Is Zura Bio Limited in the Dow Jones?

No, Zura Bio Limited is not included in the Dow Jones index

When was Zura Bio Limited's last earnings report?

Zura Bio Limited's most recent earnings report was on Mar 25, 2025

When does Zura Bio Limited report earnings?

The next expected earnings date for Zura Bio Limited is May 9, 2025

Should I buy Zura Bio Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page